| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired resistance to crizotinib in advanced lung adenocarcinoma with MET exon 14 skipping
|
Zhang, Yu
|
|
2017
|
113 |
C |
p. 69-71
|
artikel
|
| 2 |
An international epidemiological analysis of young patients with non-small cell lung cancer (AduJov-CLICaP)
|
Corrales-Rodríguez, Luis
|
|
2017
|
113 |
C |
p. 30-36
|
artikel
|
| 3 |
CD13 as target for tissue factor induced tumor vascular infarction in small cell lung cancer
|
Schmidt, Lars Henning
|
|
2017
|
113 |
C |
p. 121-127
|
artikel
|
| 4 |
CD44 variant–dependent regulation of redox balance in EGFR mutation–positive non–small cell lung cancer: A target for treatment
|
Kawano, Yuko
|
|
2017
|
113 |
C |
p. 72-78
|
artikel
|
| 5 |
Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma
|
Abdel-Rahman, Omar
|
|
2017
|
113 |
C |
p. 128-133
|
artikel
|
| 6 |
Contents
|
|
|
2017
|
113 |
C |
p. iv-v
|
artikel
|
| 7 |
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
|
Horn, Leora
|
|
2017
|
113 |
C |
p. 51-58
|
artikel
|
| 8 |
Editorial Board
|
|
|
2017
|
113 |
C |
p. iii
|
artikel
|
| 9 |
EGFR mutation prevalence in Asia-Pacific and Russian patients with advanced NSCLC of adenocarcinoma and non-adenocarcinoma histology: The IGNITE study
|
Han, Baohui
|
|
2017
|
113 |
C |
p. 37-44
|
artikel
|
| 10 |
External validation of prognostic indices for overall survival of malignant pleural mesothelioma
|
Kataoka, Yuki
|
|
2017
|
113 |
C |
p. 88-92
|
artikel
|
| 11 |
Frequency and clinical impact of preoperative circulating tumor cells in resectable non-metastatic lung adenocarcinomas
|
Dandachi, Nadia
|
|
2017
|
113 |
C |
p. 152-157
|
artikel
|
| 12 |
Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies
|
Liu, Caiyang
|
|
2017
|
113 |
C |
p. 18-29
|
artikel
|
| 13 |
Heterogeneous resistance mechanisms in an EGFR exon 19-mutated non-small cell lung cancer patient treated with erlotinib: Persistent FGFR3-mutation, localized transformation to EGFR-mutated SCLC, and acquired T790M EGFR-mutation
|
Santoni-Rugiu, Eric
|
|
2017
|
113 |
C |
p. 14-17
|
artikel
|
| 14 |
Immunohistochemical and genetic characteristics of lung cancer mimicking organizing pneumonia
|
Ichikawa, Tomohiro
|
|
2017
|
113 |
C |
p. 134-139
|
artikel
|
| 15 |
Inter-relationship between PD-L1 expression and clinic-pathological features and driver gene mutations in pulmonary sarcomatoid carcinomas
|
Lococo, Filippo
|
|
2017
|
113 |
C |
p. 93-101
|
artikel
|
| 16 |
Nanoparticle targeted folate receptor 1-enhanced photodynamic therapy for lung cancer
|
Kato, Tatsuya
|
|
2017
|
113 |
C |
p. 59-68
|
artikel
|
| 17 |
Next-generation sequencing reveals novel resistance mechanisms and molecular heterogeneity in EGFR-mutant non-small cell lung cancer with acquired resistance to EGFR-TKIs
|
Lee, Choong-kun
|
|
2017
|
113 |
C |
p. 106-114
|
artikel
|
| 18 |
Patient-reported outcome measures (PROMs) in the management of lung cancer: A systematic review
|
Bouazza, Youssef Ben
|
|
2017
|
113 |
C |
p. 140-151
|
artikel
|
| 19 |
PD-L1 IHC in NSCLC with a global and methodological perspective
|
Thunnissen, Erik
|
|
2017
|
113 |
C |
p. 102-105
|
artikel
|
| 20 |
Predictors for chemotherapy in early stage small cell lung carcinoma (SCLC): A National Cancer Database (NCDB) analysis
|
Ahmed, Zaheer
|
|
2017
|
113 |
C |
p. 85-87
|
artikel
|
| 21 |
Radiological classification of multiple lung cancers and the prognostic impact based on the presence of a ground glass opacity component on thin-section computed tomography
|
Hattori, Aritoshi
|
|
2017
|
113 |
C |
p. 7-13
|
artikel
|
| 22 |
Relationship between nodule count and lung cancer probability in baseline CT lung cancer screening: The NELSON study
|
Heuvelmans, Marjolein A
|
|
2017
|
113 |
C |
p. 45-50
|
artikel
|
| 23 |
Short communication: Diagnosis of lung cancer increases during the annual southeast Asian haze periods
|
Hassan, A.
|
|
2017
|
113 |
C |
p. 1-3
|
artikel
|
| 24 |
Sorafenib and continued erlotinib or sorafenib alone in patients with advanced non-small cell lung cancer progressing on erlotinib: A randomized phase II study of the Sarah Cannon Research Institute (SCRI)
|
Spigel, David R.
|
|
2017
|
113 |
C |
p. 79-84
|
artikel
|
| 25 |
Symptomatic pseudo-progression followed by significant treatment response in two lung cancer patients treated with immunotherapy
|
Hochmair, Maximilian J.
|
|
2017
|
113 |
C |
p. 4-6
|
artikel
|
| 26 |
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study
|
Talbot, Toby
|
|
2017
|
113 |
C |
p. 115-120
|
artikel
|
Tijdschrift beschrijving